Abnormal protein kinase activities and the corresponding changes in the protein phosphorylation state have been implicated in the onset of tumor formation and cancer progression7; and therefore become attractive targets for the development of therapeutic agents to treat cancer as well as drug resistance8, 9. Here, WEE1 is linked to cancer.